Affordable Pharmacovigilance Software for CROs and Small Pharma in India

India has become one of the world's most important hubs for pharmacovigilance — home to a large share of global CRO and safety-outsourcing capacity, alongside a fast-growing domestic pharma sector. Yet the leading safety platforms were designed and priced for large multinational marketing authorisation holders. For a CRO juggling multiple sponsors, or a small-to-mid pharma company, that model is often a poor fit. This guide explains the alternative.

#The mismatch: enterprise suites vs CRO / SMB reality

Legacy enterprise platforms assume you have an internal IT and infrastructure team, budget for multi-month implementations, and enough seats to justify heavy per-user licensing. A CRO onboarding a new sponsor next month, or an SMB pharma with a lean safety team, rarely has any of those. The capability is needed; the cost structure and setup burden are not.

#What 'affordable' should actually mean

Affordable does not mean stripped-down. A genuinely cost-effective PV platform lowers cost structurally — through modern infrastructure and a sensible licensing model — while still covering the full ICSR workflow. The savings come from how it is built and hosted, not from cutting compliance or capability.

• No client-side IT setup — fully hosted SaaS with no servers to procure or maintain
• Fast provisioning — a tenant ready to configure in days, not months
• A licensing model that scales with actual need, not heavy per-seat fees
• A built-in AS2 gateway, so regulatory submission does not need a separately licensed gateway
• AI-assisted intake to reduce manual case-processing effort as volume grows

#What CROs specifically need

CROs have a particular shape of requirement: they serve many sponsors at once, each with different reporting rules, and they are judged on on-time submission metrics. A platform that fits a CRO should offer logically isolated tenants per sponsor, configurable reporting rules, and a submission-compliance dashboard that surfaces the monthly KPIs sponsors expect. Once the platform is live, onboarding each new sponsor should be near-instant rather than a fresh project.

#Affordable, but still GxP-aligned

Cost-effectiveness cannot come at the expense of inspection readiness. Any platform you choose should be designed around 21 CFR Part 11, EU GVP, and GAMP 5, with full audit logging, role-based access control, tenant data isolation, and electronic signatures. Modern technology and compliance are not a trade-off — see our guide to 21 CFR Part 11 in pharmacovigilance for what that involves in practice.

#Data residency and regional hosting

For India-based operations serving global sponsors, data residency often appears in contracts. A capable platform offers regional hosting options — EU, US, or India — so GDPR and sponsor-specific data-location requirements can be met without changing systems.

#A short evaluation checklist

1. 1Does it cover the full ICSR lifecycle — intake, coding, assessment, submission?
2. 2Is it truly hosted with zero client-side IT setup?
3. 3How fast can a new tenant or sponsor be onboarded?
4. 4Is the AS2/E2B gateway built in or a paid add-on?
5. 5Does it provide IQ/OQ/PQ documentation to support your validation?
6. 6Are there India / EU / US hosting options for data residency?
7. 7Does the pricing model match a CRO or SMB shape, not enterprise per-seat?

PVgenix was built for exactly this segment: a modern, GxP-aligned, AI-assisted platform for end-to-end ICSR processing, delivered as fully hosted SaaS at a cost profile suited to CROs and small-to-mid pharma. If that matches your situation, the platform overview and Why PVgenix pages are the best next step.